Investor Presentaiton slide image

Investor Presentaiton

Definitions DRUG CATEGORY New Drugs Branded Generics Non-Branded Generics (Similar Drugs) DEFINITIONS Innovative products for which safety, efficacy and quality have been proven via multiple non-clinical and clinical studies before registration with Anvisa. Products that contain the same active ingredient(s), has the same concentration, dosage form, administration route, dosage administration and therapeutic recommendation, as the reference drug registered with Anvisa. It may differ only in the product's size and form, expiration date, packaging, labelling, excipients, and it must always be identified by trade name or brand name. Products that contain the same active ingredient, formulation, pharmaceutical form, mode of administration, dosage and indication than the reference drug that drugs already registered with Anvisa. They are intended to be interchangeable with the reference product.
View entire presentation